152 related articles for article (PubMed ID: 36252813)
21. Gintonin modulates platelet function and inhibits thrombus formation via impaired glycoprotein VI signaling.
Irfan M; Jeong D; Saba E; Kwon HW; Shin JH; Jeon BR; Kim S; Kim SD; Lee DH; Nah SY; Rhee MH
Platelets; 2019; 30(5):589-598. PubMed ID: 29870296
[TBL] [Abstract][Full Text] [Related]
22. IL-37 Attenuates Platelet Activation and Thrombosis Through IL-1R8 Pathway.
Chen Y; Hong J; Zhong H; Zhao Y; Li J; Shen W; Luo X; Shi H; Hu L; Liu J; Gao W
Circ Res; 2023 Apr; 132(9):e134-e150. PubMed ID: 36999436
[TBL] [Abstract][Full Text] [Related]
23. Distinct phosphodiesterase 5A-containing compartments allow selective regulation of cGMP-dependent signalling in human arterial smooth muscle cells.
Wilson LS; Guo M; Umana MB; Maurice DH
Cell Signal; 2017 Aug; 36():204-211. PubMed ID: 28506928
[TBL] [Abstract][Full Text] [Related]
24. [Inhibitory effects and mechanisms of snake venom tripeptide pENW on platelet adhesion].
Bai L; Fang WR; Kong Y; Li YM
Yao Xue Xue Bao; 2015 Sep; 50(9):1107-15. PubMed ID: 26757546
[TBL] [Abstract][Full Text] [Related]
25. Modulation of platelet activation and thrombus formation using a pan-PI3K inhibitor S14161.
Yi W; Li Q; Shen J; Ren L; Liu X; Wang Q; He S; Wu Q; Hu H; Mao X; Zhu L
PLoS One; 2014; 9(8):e102394. PubMed ID: 25115838
[TBL] [Abstract][Full Text] [Related]
26. Antiplatelet Activity of a Newly Synthesized Novel Ruthenium (II): A Potential Role for Akt/JNK Signaling.
Khamrang T; Hung KC; Hsia CH; Hsieh CY; Velusamy M; Jayakumar T; Sheu JR
Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28448438
[TBL] [Abstract][Full Text] [Related]
27. The P2Y(12) antagonists, 2MeSAMP and cangrelor, inhibit platelet activation through P2Y(12)/G(i)-dependent mechanism.
Xiang B; Zhang G; Ren H; Sunkara M; Morris AJ; Gartner TK; Smyth SS; Li Z
PLoS One; 2012; 7(12):e51037. PubMed ID: 23236426
[TBL] [Abstract][Full Text] [Related]
28. Tangeretin regulates platelet function through inhibition of phosphoinositide 3-kinase and cyclic nucleotide signaling.
Vaiyapuri S; Ali MS; Moraes LA; Sage T; Lewis KR; Jones CI; Gibbins JM
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2740-9. PubMed ID: 24135020
[TBL] [Abstract][Full Text] [Related]
29. cAMP- and cGMP-elevating agents inhibit GPIbα-mediated aggregation but not GPIbα-stimulated Syk activation in human platelets.
Makhoul S; Trabold K; Gambaryan S; Tenzer S; Pillitteri D; Walter U; Jurk K
Cell Commun Signal; 2019 Sep; 17(1):122. PubMed ID: 31519182
[TBL] [Abstract][Full Text] [Related]
30. ARHGEF10 knockout inhibits platelet aggregation and protects mice from thrombus formation.
Lu DH; Hsu CC; Huang SW; Tu HJ; Huang TF; Liou HC; Liao HM; Chen CH; Fu WM; Gau SS
J Thromb Haemost; 2017 Oct; 15(10):2053-2064. PubMed ID: 28799234
[TBL] [Abstract][Full Text] [Related]
31. Humanin analogue, HNG, inhibits platelet activation and thrombus formation by stabilizing platelet microtubules.
Ren L; Li Q; You T; Zhao X; Xu X; Tang C; Zhu L
J Cell Mol Med; 2020 Apr; 24(8):4773-4783. PubMed ID: 32174022
[TBL] [Abstract][Full Text] [Related]
32. Multidrug resistance protein 4 (MRP4/ABCC4) regulates thrombus formation in vitro and in vivo.
Lien LM; Chen ZC; Chung CL; Yen TL; Chiu HC; Chou DS; Huang SY; Sheu JR; Lu WJ; Lin KH
Eur J Pharmacol; 2014 Aug; 737():159-67. PubMed ID: 24836986
[TBL] [Abstract][Full Text] [Related]
33.
Irfan M; Kwon HW; Lee DH; Shin JH; Yuk HJ; Kim DS; Hong SB; Kim SD; Rhee MH
Front Pharmacol; 2020; 11():698. PubMed ID: 32508642
[TBL] [Abstract][Full Text] [Related]
34. Modulation of human platelet activation and in vivo vascular thrombosis by columbianadin: regulation by integrin α
Hou SM; Hsia CW; Tsai CL; Hsia CH; Jayakumar T; Velusamy M; Sheu JR
J Biomed Sci; 2020 May; 27(1):60. PubMed ID: 32375785
[TBL] [Abstract][Full Text] [Related]
35. FUNDC2 regulates platelet activation through AKT/GSK-3β/cGMP axis.
Ma Q; Zhang W; Zhu C; Liu J; Chen Q
Cardiovasc Res; 2019 Sep; 115(11):1672-1679. PubMed ID: 30576423
[TBL] [Abstract][Full Text] [Related]
36. A novel antithrombotic effect of sulforaphane via activation of platelet adenylate cyclase: ex vivo and in vivo studies.
Jayakumar T; Chen WF; Lu WJ; Chou DS; Hsiao G; Hsu CY; Sheu JR; Hsieh CY
J Nutr Biochem; 2013 Jun; 24(6):1086-95. PubMed ID: 23246160
[TBL] [Abstract][Full Text] [Related]
37. Inhibitory effects of lycopene on in vitro platelet activation and in vivo prevention of thrombus formation.
Hsiao G; Wang Y; Tzu NH; Fong TH; Shen MY; Lin KH; Chou DS; Sheu JR
J Lab Clin Med; 2005 Oct; 146(4):216-26. PubMed ID: 16194683
[TBL] [Abstract][Full Text] [Related]
38. Ca
Tamang HK; Yang RB; Song ZH; Hsu SC; Peng CC; Tung YC; Tzeng BH; Chen CC
J Thromb Haemost; 2022 Aug; 20(8):1887-1899. PubMed ID: 35490411
[TBL] [Abstract][Full Text] [Related]
39. A noble function of BAY 11-7082: Inhibition of platelet aggregation mediated by an elevated cAMP-induced VASP, and decreased ERK2/JNK1 phosphorylations.
Lee HS; Kim SD; Lee WM; Endale M; Kamruzzaman SM; Oh WJ; Cho JY; Kim SK; Cho HJ; Park HJ; Rhee MH
Eur J Pharmacol; 2010 Feb; 627(1-3):85-91. PubMed ID: 19913011
[TBL] [Abstract][Full Text] [Related]
40. Atractylodes lactone compounds inhibit platelet activation.
Chen Y; Yang W; Guo L; Wu X; Zhang T; Liu J; Zhang J
Platelets; 2017 Mar; 28(2):194-202. PubMed ID: 27560602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
